APP and Alzheimer disease: Our study demonstrates that CR can reduce Aβ expression in the APP/ PS1 transgenic mouse model by suppressing inflammatory responses and oxidative stress, and CR results in the alterations in the gut microbiome leading to the attenuation of AD.